RACHEL LEBOLO: Open Payments
NPI 1801288337 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 10 payments from 7 companies in 2025. Trend: 2023 $305 · 2024 $905 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $74 |
| CVRx, Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| AtriCure, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VERQUVO, Barostim Neo System, AMVUTTRA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, WINREVAIR, Kerendia, FUROSCIX, FARXIGA.
Industry payments across GA — which companies pay providers there.
